CeraVe Skin Renewing Night Cream features a complex of biomimetic peptides, hyaluronic acid, and 3 essential ceramides that work together to lock in skin's moisture and help restore your skins protective barrier overnight.Useable for both men and women.Nig
CeraVe Skin Renewing Night Cream features a complex of biomimetic peptides, hyaluronic acid, and 3 essential ceramides that work together to lock in skin’s moisture and help restore your skins protective barrier overnight.Useable for both men and women.
Nighttime is the skins chance to help renew itself, and a properly formulated night cream provides hydrating and rejuvenating benefits. We recommend looking for formulas designed withhyaluronic acid,niacinamideandceramidesto hydrate, calm and restore the skin barrier, like our CeraVe Skin Renewing Night Cream, which also features peptides to help improve the appearance of fatigued skin.
This non-greasy, intensely moisturizing skin renewing night cream is designed to soften and renew the look of tired skin, and our patented MVE technology encapsulates ceramides to ensure efficient delivery within the skins barrier and slow release over time. Supporting your protective skin barrier, long after youve finish applying so you can wake up looking rested and rejuvenated.
AQUA / WATER / EAU, GLYCERIN, CAPRYLIC/CAPRIC TRIGLYCERIDE, BUTYROSPERMUM PARKII BUTTER / SHEA BUTTER,DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER, CYCLOPENTASILOXANE, GLYCERYL STEARATE SE, CETYL ALCOHOL, DIMETHICONE, SACCHARIDE ISOMERATE, STEARIC ACID, PALMITIC ACID, GLYCINE SOJA STEROLS / SOYBEAN STEROLS, ALLANTOIN, CERAMIDE NP, CERAMIDE AP, CERAMIDE EOP, CARBOMER, NIACINAMIDE, CETEARYL ALCOHOL, BEHENTRIMONIUM METHOSULFATE, SODIUM HYDROXIDE, MYRISTIC ACID, SODIUM LAUROYL LACTYLATE, SODIUM BENZOATE, SODIUM CITRATE, SODIUM HYALURONATE, CHOLESTEROL, PHENOXYETHANOL, TOCOPHEROL, TRIPEPTIDE-1, LAURETH-9, CITRIC ACID, CAPROOYL TETRAPEPTIDE-3, BIOSACCHARIDE GUM-1, PHYTOSPHINGOSINE, XANTHAN GUM, DEXTRAN, ETHYLHEXYLGLYCERIN, BUTYLENE GLYCOL
Reviews
There are no reviews yet.